The growing problem of co-treatment with opioids and benzodiazepines.

Citation data:

BMJ (Clinical research ed.), ISSN: 1756-1833, Vol: 356, Page: j1224

Publication Year:
2017
Captures 8
Readers 8
Mentions 8
News Mentions 7
Blog Mentions 1
Social Media 138
Tweets 125
Shares, Likes & Comments 13
Citations 1
Citation Indexes 1
PMID:
28292825
DOI:
10.1136/bmj.j1224
Author(s):
Karaca-Mandic, Pinar, Meara, Ellen, Morden, Nancy E
Publisher(s):
BMJ
Tags:
Medicine
Most Recent Tweet View All Tweets
Most Recent Blog Mention
Most Recent News Mention
article description
Since 1999, the US has witnessed a fourfold increase in deaths from overdose involving prescription opioids, 1 a fact widely known by US residents. That benzodiazepines are present in over 30% of overdoses involving prescription opioids is less well known. 2 Using claims based data from 315 428 privately insured individuals in the US with at least one filled prescription for an opioid in 2001-13, Sun and colleagues (doi:10.1136/bmj.j760) examined the prevalence of a hazardous prescription combination. 3 The risk of combining opioids and benzodiazepines has long been understood; both drug classes can be sedating, suppress respiratory efforts, impair thought, slow response time, and increase falls. 2 Sun and colleagues found an alarming rise in this prescribing practice in their study population, from 9% in 2001 to 17% in 2013. They report a significantly increased risk of overdose among patients receiving both drug types concurrently, documenting one type of harm associated with this unsound and growing clinical practice.

This article has 0 Wikipedia mention.